chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient recieved flu vaccine 10/6/09. 48 hrs after injection, patients left arm was still inflammed around injection site (left bicep and around upper arm). Symptoms consisted of  swollen, redness and inflammation which left arm was bigger than other arm. No fever or other serious symptoms associated with injection. Patient was given Predisone injection 10/8/08 and predisone dose po qd, day after to reduce inflamation. Prior to MD visit on 10/8/08, parents administered loratidine 5ml, benedryl gel, later cortisone cream which did not reduce inflamation. Parents had also contacted after hours md service which was advised to seek md for visit.
Patient reported that symptoms began the day after vaccination and included itchy welts on neck and facial swelling mainly beneath eyes. Patient also reports that his skin was peeling, mainly beneath his eyes. Patient reports that he is still having symptoms today, 1 week after vaccination, but that he's noticed improvement in symptoms over time. Patient states that using a cold compress beneath his eyes helps relieve some of the swelling below eyes.
This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever), nausea, headache, fatigue and myalgia (muscle aches, arm soreness) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 027A21A) for an unknown indication. The patient's past medical history included COVID-19 in December 2020. On Mar 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 23, 2021, patient experienced pyrexia (fever), nausea, headache, fatigue and myalgia (muscle aches, arm soreness). At the time of the report, pyrexia (fever), nausea, headache, fatigue and myalgia (muscle aches, arm soreness) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
pain on both their legs and their back; pain on both their legs and their back; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain on both their legs and their back) and PAIN IN EXTREMITY (pain on both their legs and their back) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced BACK PAIN (pain on both their legs and their back) and PAIN IN EXTREMITY (pain on both their legs and their back). At the time of the report, BACK PAIN (pain on both their legs and their back) and PAIN IN EXTREMITY (pain on both their legs and their back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded.
3 day sustained fever of 103 - 104 with very little relief from fever reducing medicine. 2 additional days of a fever of 99.5. Hallucinations both auditory and visual. Overwhelming anxiety and panic that has persisted since. Changes in eyesight (everything had a pink hue). Memory lapses.
then COVID hit and I never got the other one; This case was reported by a consumer and described the occurrence of social problem in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received 12 months ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as the reporter was the patient. The age at vaccination was not applicable for this report. The pharmacist reported that, the patient did not receive 2nd dose of Shingrix due to COVID pandemic situation, which led to social problem. The reporter asked if need to restart again.
4/28/21- Received Second dose Pfizer COVID-19 Vaccine 4/29/21- Thursday, no temp developed fatigue and body aches 4/30/21 -Friday developed dizziness upon standing, went to bed hoping it would be improved in the morning 05/01/21- Saturday morning woke up with severe vertigo, nausea, vomiting and diarrhea which prompted a trip to the Emergency Department and Admission to the hospital from 05/01/21 to 05/04/21 for vestibular neuritis, with concern that this was possibly related to Pfizer COVID-19 second dose.   Treatment included IV fluids, antiemetics, medication for dizziness, evaluation by PT for dizziness and instability with walking, as well as possible BPPV although onset of symptoms did not completely align with that consideration. She had slow improvement and was started on steroid taper. Discharge home for ongoing recovery and supportive care.
patient received booster dose 5 months after second dose instead of 6 months; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received booster dose 5 months after second dose instead of 6 months) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A, 038B21A and 076C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received booster dose 5 months after second dose instead of 6 months). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received booster dose 5 months after second dose instead of 6 months) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment informations were reported.    This case was linked to MOD-2021-366704 (Patient Link).
3 months after receiving my second pfizer vaccine I was hospitalized and diagnosed with Bilateral Pulmonary Embolisms. The clots were found via a VQ scan. I am currently on my 5th month of blood thinners and once my 6th month is completed I will get another VQ scan to confirm that status of the clots.
Shingles outbreak started in right armpit.  spread to mid chest to mid back wrapping through armpit; first dose of bnt162b2 on 24Jan2021 01:00 PM/ bnt162b2, dose 2 on 10Feb2021 10:00; first dose of bnt162b2 on 24Jan2021 01:00 PM/ bnt162b2, dose 2 on 10Feb2021 10:00; This is a spontaneous report from a contactable consumer (patient). A 45-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EL9269), dose 2 via an unspecified route of administration, administered in Arm Right on 10Feb2021 10:00 (45-years-old) as single dose for COVID-19 immunization. Medical history included Surgery left shoulder from 07Jan2021 to 07Jan2021 (so injection was in right arm). No known allergies. Patient was not pregnant. Patient had no covid prior vaccination. Patient was tested for covid post vaccination. Facility type vaccine was Hospital. Concomitant medication included naproxen sodium (ALEVE) start and stop date were not reported (stopped 48hrs before). The patient previously took first dose of bnt162b2 (lot number: EL9262) on 24Jan2021 01:00 PM (45-years-old) on right arm for COVID-19 immunization. The patient experienced shingles outbreak, started in right armpit and has spread to mid chest to mid back wrapping through armpit on 20Feb2021 07:00, resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient underwent lab tests and procedures which included RT-PCR (Nasal Swab): Negative on 24Feb2021. The outcome of the event Shingles was recovering. Therapeutic measures were taken as a result of event, medication (valtrex, gabapentin,codeine#3).
very, very sore arm; This is a spontaneous report from a contactable consumer (patient) via medical information team. An 80-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9261; Expiration Date: 31May2021), via an unspecified route of administration administered in left arm on 05Feb2021 at 10:40 (age at vaccination was 80 years) as 1st dose, single for COVID-19 immunization. The patient's medical history included high blood pressure, acid reflux, allergies to like cats and stuff like to tree if she got too close to them, she smoked for years 2 puffs every other morning, she had some beginning touches of COPD she thinks. She had a lot of problems or anything with COPD, she just got out of breath sometimes, but she was also getting old. Patient concomitant medication included amlodipine (AMLODIPINE) and hydrochlorothiazide, losartan potassium (LOSARTAN/HCTZ) both taken for high blood pressure been on this product for years and ongoing, omeprazole (OMEPRAZOLE) taken for acid reflux, tiotropium bromide (SPIRIVA) taken for chronic obstructive pulmonary disease from an unspecified start date and ongoing and atorvastatin (ATORVASTATIN) taken for an unspecified indication from an unspecified start date and ongoing. Patient was on no blood thinners. The patient's family history included one sister was dead, had asthma and allergic to everything. Her other sister had a heart attack and recovered very well but she was only 62 years old. One of her brothers died of brain cancer; and another brother died in his sleep of a heart attack. They have a lot of heart problems in the family. Her mother also had a heart attack and recovered but was no longer with us but also had emphysema. Her father died in 1968 of the Hong Kong Flu. The patient previously got the Flu shot on unspecified date in Sep2020 and had kind of punky/punchy/ugh; but nothing where it keeps her down in bed or anything like that. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had no additional vaccines administered on same date of the Pfizer suspect. On 05Feb2021 around 12:00-13:00 the patient experienced very, very sore arm and it does not seem to be getting any better. The patient inquired if she could take Tylenol or Motrin for the very, very sore arm and if it will reduce the effect of the vaccine, as she was scheduled to had second dose on 26Feb2021. The outcome of the event was not recovered.  Follow-up attempts completed. No further information expected.
Immediate dizziness and nauseous. Took 20 minutes to resolve. After 12 hours had extreme fatigue and muscle aches that lasted for 2 days.  Could still feel some mild symptoms 4 days after the injection.
This spontaneous report as received from a Medical Assistant refers to a 9 week old patient, gender not reported. On 03-NOV-2014, the patient was vaccinated with ROTATEQ, Lot # K002991, orally. It was reported that the administered vaccine was subjected to temperature excursion. No adverse events were reported. This is one of the several reports from the same reporter. Additional information has been requested.
11/16/09. Foster mother stated child experienced no problems from vaccine - stated "no runny nose or anything-sis not even have to give him TYLENOL." No adverse event. Misadministration of vaccine; vaccine not licensed for this age.
5 people she knew were vaccinated and died; This is a spontaneous report received from Pfizer sponsored program from a non-contactable consumer. This consumer reported same event for 5 patients. This is the 1st of 5 reports.  A female patient of unspecified age received bnt162b2 (COMIRNATY), via unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The consumer stated during conversation that 5 people she knew were vaccinated and died. She did not have any other information. The patient died on an unspecified date. It was unknown if an autopsy was performed. The outcome of the event was fatal.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER_INC-202101451923 same reporter/drug/event, different PTs;US-PFIZER_INC-202101451924 same reporter/drug/event, different PTs;US-PFIZER_INC-202101451925 same reporter/drug/event, different PTs;US-PFIZER_INC-202101451926 same reporter/drug/event, different PTs; Reported Cause(s) of Death: 5 people she knew were vaccinated and died.
The child received his 4th injection of Infanrix on 10/7/99. On 11/24/99, 48 days post vax, he reportedly experienced an upper respiratory tract infection. His mother reported that he stopped sleeping at night and became very restless. He then "regressed into autism". As of 11/15/01, the autism was ongoing. Outcome of the upper respiratory tract infection was not specified. This report of autism is considered "medically Serious". The mother reported that the pt received Infanrix from lot DTPA9909AZ; however, this is not a valid not number.
Fever started at 11am and lasted 24 hours, going up to 103 at some points.
Spontaneous report received on 17JUL2015. On 17JUL2015, an approximately 20 year old male medical technician was accidentally squirted in the eye with BioThrax vaccine solution while administering vaccine to another serviceman. The reporter stated that the syringe malfunctioned allowing the BioThrax vaccine solution (LOT FAV427A) to project toward the personnel administering the vaccine. Of the 0.5ml dose, it was estimated that approximately a half to a quarter of the solution made contact with the medical technician's eye. He reportedly flushed his eye for 22 minutes immediately following the exposure. He was then seen by a medical professional and also had an eye exam. No adverse reactions were noted at the time of the examinations. On 20JUL2015, he was  doing fine and showed no adverse reactions. No further information was provided. Sender's Comments: Occupational exposure without adverse event; Not assessable.
Burning; Redness and inflammation at the injection site; Redness and inflammation at the injection site; Itching; This is a spontaneous report from a contactable physician, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 15:15 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included mild COPD, PCOS, cervical dysplasia and HPV positive. The patient was allergic to tape. Concomitant medications oral contraceptives included and paracetamol (MANUFACTURER UNKNOWN) if necessary. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021, the patient underwent COVID-19 PCR test and the result was negative. On 31Mar2021, the patient experienced redness and inflammation at the injection site. It was itching and burning. It appeared on day 8 post vaccination. It was reported that it seems a delayed toxicity. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the redness and inflammation at the injection site, itching and burning was resolving at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Arm soreness throughout entire arm hours 2-24 post vaccine, peak about 12hr then relenting.  Myalgias sporadic and brief, with fatigue, 36 hours post vaccine, resolution within 12 hours.
my second vaccine was on april 6th . i was at the pharmacy with my husband on april 10th for his vaccination at 2:00pm, while waiting and sitting down if felt a sudden strange sensation  like falling of a cliff or downhill, not sure if i was going to faint , felt very unsteady. was flushed in the chest and face. they took my BP. it was 183/96. I have to history of high blood pressure. it is always normal. they suggested i go to the ER.  I did immediately to  Medical Center. Was admitted overnight. The Dr was the hospital floor doctor at the time.  I have had follow up appts with my family doctor since.
Received shot and that night about 2 am woke up with extreme joint and muscle pain everywhere unable to stop the pain, it was so  extreme I was on the floor crying, My husband had to help me out of bed. This pain traveled throughout my body and I was unable to raise my arms from my side as well as my legs didn't work either all with lots of pain. My muscles jerk and some times have no energy to even stand up. My doctor ran every test there was to rule out Lupus, RA, Tumors and other stuff, all negative, he did say that he thought it to be Serum Poisoning. From the Perservative in the flu shot, Thimerosal. I have been so sick ever since. I have not worked, unable to clean my house or cook, watch my grand child, my life stopped, and I had to take drugs around the clock even writing every dose down so I would not over dose. Had to take Zoloft ( never took this before) Pain killer Ultram, IB 800mg. Plus many vitamins and detox, Chiropractors, accupucture, Lotions. I've spent alot of money to get this out of my body and get my life back, but they said it would take about 6 months and it has been 5 and I can finally think enough to write this down. I walked the floor at nights to just ease the pain so not much sleep I thought I was losing my mind. I'm still on the drugs but better then before. My mind forgets lots of things that happened I have to ask my family. This is something I will never do again, I will just have to die from the flu if thats the case, it would be quicker.
Approximately one week following vax, the pt began to have very bad headaches and arm pain at the injection site, along with some pain in her foot. She did not seek medical attention.
She suffered a minor heart attack; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient husband  A female patient received BNT162b2 (BNT162B2), in Feb2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (hospitalization, medically significant) with onset Feb2021, outcome "unknown", described as "She suffered a minor heart attack". Therapeutic measures were taken as a result of myocardial infarction.  Additional information: My wife (hysterically) woke me up at 5:30 a.m. in early Feb2021, complaining of chest discomfort and shooting pain down her left arm. I sat her down right away and dialed 911 to request an ambulance from emergency services. She suffered a minor heart attack, which was treated at a nearby hospital.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Parents stated that at around 6pm on 1/10/2019, they noticed child was crying and left eye was slightly swollen. Assessed by Dr., few scratches on the forehead, and few small rash was noticed on the upper back, not swollen. No nasal flaring or stridor. No respiratory distress. No wheezing. Patient was sent to ER for further observation. ER notes as follows: Physical Exam Constitutional: She appears well-developed and well-nourished. She is active. HENT: Head: Anterior fontanelle is flat. Right Ear: Tympanic membrane normal. Left Ear: Tympanic membrane normal. Nose: Nose normal. Mouth/Throat: Mucous membranes are moist. Oropharynx is clear. NO PERIORAL OR PERIORBITAL EDEMA. Eyes: Conjunctivae are normal. Red reflex is present bilaterally. Pupils are equal, round, and reactive to light. Neck: Normal range of motion. Neck supple. Pulmonary/Chest: Effort normal and breath sounds normal. No nasal flaring or stridor. No respiratory distress. She has no wheezes. She exhibits no retraction. Abdominal: Soft. Bowel sounds are normal. She exhibits no distension. There is no tenderness. There is no rebound and no guarding. Musculoskeletal: Normal range of motion. She exhibits no tenderness. Lymphadenopathy: No occipital adenopathy is present. She has no cervical adenopathy. Neurological: She is alert. She has normal strength and normal reflexes. Suck normal. Skin: Skin is warm and moist. Capillary refill takes less than 3 seconds. Turgor is normal. Rash noted. Erythematous rash almost resolved blotchy to upper back no rash to neck at present. Nursing note and vitals reviewed.
Unsure of cause/effect.  Patient developed idiopathic thrombocytopenic purpura with platelets of 4000 from normal the month prior.  With most recent different events being the COVID-19 vaccination and starting prolia twice yearly for osteoporosis.  She developed purpura on left arm starting on 4/18 which enlarged and coalesced throughout the week.  She then developed oozing from known wound and purpura on chest.  Entire left arm developed diffuse bruising and swelling by 4/22.  Left side of face also with spontaneous bruising.  Developed mucosal bleeding of mouth and throat on 4/22.  Presented tachycardic and mildly hypotensive.
lost hearing in right ear; ringing in the ear; A spontaneous report was received from a 62-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced ringing in the ear and loss of hearing in the right.  The patient's medical history was not provided. Products known to have been used by the patient were not included.  On 03 Feb 2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.    On an unspecified date, the patient experienced ringing in the ear and lost hearing in the right ear.   Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, ringing in the ear and  lost hearing in the right ear was not reported.; Reporter's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
Information has been received from a Registered Nurse concerning a nurse who on an unspecified date developed shingles after administering Zostavax (Oka/Merck).  At the time of the report the patinet's status was unknown. It was unspecified if medical attention was sought. There is no product quality complaint involved, no additional information was provided.  Additional information requested.  This is one of several reports from the same source.
Since 2nd dose on 3/29/2021, redness and soreness remains.
Pt experienced a vasovagal episode and emesis x1 post-vaccination at 11:30 AM. BP manually measured at 128/78, pulse ~100, O2 sat 100%. Pt instructed to recline to the supine position and episode self resolved without further sequelae.